Synthetic gut communities reveal how diet rewires the microbiome
View as a Web Page
News Medical
 
  Bowel Cancer Bowel Cancer logo  
  The latest bowel cancer news from News Medical  
 New human protein atlas maps how cancer rewires the body’s tissuesNew human protein atlas maps how cancer rewires the body’s tissues
 
Researchers created a DIA-MS atlas of 13,609 proteins across 2,856 samples from fetal, healthy adult, paired non-tumor, and tumor tissues. The resource maps tissue-specific protein patterns, cancer-associated changes, organ-specific drug-toxicity signals, and candidate therapeutic targets.
 
 
 Synthetic gut communities reveal how diet rewires the microbiomeSynthetic gut communities reveal how diet rewires the microbiome
 
Synthetic microbial communities give researchers controlled models for testing how diet reshapes gut microbial ecology, metabolism, and host-relevant responses. The review highlights how SynComs can strengthen causal inference, improve intervention testing, and support future precision nutrition, while noting major challenges in stability, standardization, and ecological realism.
 
   Study identifies risk factors for early-onset colorectal cancerStudy identifies risk factors for early-onset colorectal cancer
 
A recent study found that factors such as a person's birthweight, sex, ethnicity, and father's age may affect the risk of being diagnosed with colorectal cancer at a young age.
 
   Accelerated biological aging may drive rising early-onset cancer riskAccelerated biological aging may drive rising early-onset cancer risk
 
Cancer is often considered a disease of aging. Older adults are at higher risk because they have had more time to accumulate cellular damage that can trigger tumor formation.
 
   New drug could double survival time in patients with advanced pancreatic cancerNew drug could double survival time in patients with advanced pancreatic cancer
 
A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in The New England Journal of Medicine.
 
 Researchers advocate local data strategies for early cancer detection
 
Researchers advocate local data strategies for early cancer detectionResearchers are calling for the application of locally driven strategies, supported by stronger regional evidence, to improve early cancer detection and precise care.
 
 
 Eating 90 g of wholegrains daily linked to lower breast cancer risk
 
Eating 90 g of wholegrains daily linked to lower breast cancer riskResearch indicates that long-term wholegrain intake per Nordic guidelines is associated with reduced breast cancer risk, emphasizing food type differences.
 
 
 Colorectal cancer cases rise among younger adults in Germany
 
Colorectal cancer cases rise among younger adults in GermanyColorectal cancer is generally considered a disease of older adults. However, a new analysis of German cancer registries shows that the number of new colorectal cancer cases among younger adults has risen slightly over the past two decades.
 
 
 AACR report highlights unequal burden of cancer in the United States
 
AACR report highlights unequal burden of cancer in the United StatesThe American Association for Cancer Research (AACR) today released its Cancer Disparities Progress Report 2026, a comprehensive analysis of the unequal burden of cancer in the United States.
 
 
 Comprehensive gut microbiome analysis reveals robust colorectal cancer signature
 
Comprehensive gut microbiome analysis reveals robust colorectal cancer signatureResearchers have long suspected that the gut microbiome – the community of bacteria and other microorganisms living in the intestine – is closely linked to colorectal cancer.
 
 
 Natural microbial compound helps protect the gut from chronic inflammation
 
Natural microbial compound helps protect the gut from chronic inflammationUniversity of Louisville researchers have discovered how a naturally occurring microbial compound may help protect the gut and support future treatment strategies for inflammatory bowel disease (IBD).
 
 
 GATA6 loss transforms colorectal cancer cells into metastatic states
 
GATA6 loss transforms colorectal cancer cells into metastatic statesLoss of GATA6-a transcription factor that controls which genes are turned on or off-can reprogram colorectal cancer cells into more primitive, adaptable states that can then spread to the liver and establish new tumors, according to Weill Cornell Medicine and Massachusetts Institute of Technology researchers.
 
 
 LMU researchers discover new genetic cause of Crohn's disease
 
LMU researchers discover new genetic cause of Crohn's diseaseA team led by LMU physician Daniel Kotlarz has identified a previously unknown genetic cause of Crohn's disease.
 
 
 Using blood proteomics to identify pediatric inflammatory bowel disease risk
 
Using blood proteomics to identify pediatric inflammatory bowel disease riskFor children with suspected inflammatory bowel disease (IBD), a chronic, relapsing condition of the gastrointestinal tract, getting the right diagnosis relies on a combination of clinical evaluation, imaging, endoscopy, and histopathology.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026